A detailed history of Aureus Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aureus Asset Management, LLC holds 24,297 shares of JNJ stock, worth $3.75 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
24,297
Previous 27,191 10.64%
Holding current value
$3.75 Million
Previous $3.97 Million 0.93%
% of portfolio
0.26%
Previous 0.28%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $421,019 - $484,397
-2,894 Reduced 10.64%
24,297 $3.94 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $359,650 - $393,029
-2,491 Reduced 8.39%
27,191 $3.97 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $277,999 - $291,467
-1,791 Reduced 5.69%
29,682 $4.7 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $895,585 - $977,270
-6,151 Reduced 16.35%
31,473 $4.93 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $133,166 - $149,180
855 Added 2.33%
37,624 $5.86 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $1.39 Million - $1.5 Million
-9,017 Reduced 19.69%
36,769 $6.09 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $81,567 - $97,340
540 Added 1.19%
45,786 $7.1 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $35,564 - $39,913
222 Added 0.49%
45,246 $7.99 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $330,081 - $367,297
-2,046 Reduced 4.35%
45,024 $7.36 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $1.14 Million - $1.26 Million
6,787 Added 16.85%
47,070 $8.36 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $605,834 - $688,009
-3,831 Reduced 8.68%
40,283 $7.14 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $888,333 - $985,637
-5,697 Reduced 11.44%
44,114 $7.55 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $119,348 - $132,628
739 Added 1.51%
49,811 $8.04 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $3.27 Million - $3.51 Million
20,489 Added 71.68%
49,072 $8.08 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $534,367 - $595,145
3,491 Added 13.91%
28,583 $4.7 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $242,547 - $278,405
-1,769 Reduced 6.59%
25,092 $3.95 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $9,265 - $10,152
-66 Reduced 0.25%
26,861 $4 Million
Q2 2020

Aug 11, 2020

BUY
$128.81 - $155.51 $115,542 - $139,492
897 Added 3.45%
26,927 $3.79 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $559,701 - $775,493
5,036 Added 23.99%
26,030 $3.41 Million
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $212,287 - $243,822
-1,665 Reduced 7.35%
20,994 $3.06 Million
Q3 2019

Nov 12, 2019

SELL
$126.95 - $142.14 $67,537 - $75,618
-532 Reduced 2.29%
22,659 $2.93 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $464,139 - $510,465
-3,539 Reduced 13.24%
23,191 $3.23 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $63,362 - $70,454
-504 Reduced 1.85%
26,730 $3.74 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $171,116 - $205,941
-1,393 Reduced 4.87%
27,234 $3.51 Million
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $101,640 - $119,447
-836 Reduced 2.84%
28,627 $3.96 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $131,578 - $145,199
-1,102 Reduced 3.61%
29,463 $3.58 Million
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $37,905 - $44,886
-303 Reduced 0.98%
30,565 $3.92 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $70,333 - $76,980
536 Added 1.77%
30,868 $4.31 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $3.93 Million - $4.11 Million
30,332
30,332 $3.94 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Aureus Asset Management, LLC Portfolio

Follow Aureus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.